< Back

April, 2019

Four Hurdles Have Varying Impacts Across Countries

Global Market Access Insights | April 2019

Four Hurdles Have Varying Impacts Across Countries

Four biosimilar hurdles

Download Complimentary Research Slide

Key questions:

  • What are the regulatory, legal and market access challenges for biosimilar entrants in the UK, France and Germany versus the US?
  • What can be learned from the difference in biosimilar uptake and experience between countries?
  • How have biosimilars affected  market volume, share and price? What could this imply for the future US market?

These and other findings can be found in Health Strategies Group’s recently released research Global Biosimilars Risk and Opportunities: Focus on European Union and United States

View the Research Agenda

Visit our Global Market Access Insights webpage to learn more about this research.

Want access to more leading research? Click here to request more information.

Disclaimer

 

Please complete the form to have this document sent to your email.

 

Please complete the form to have this document sent to your email.